0000899243-23-010574.txt : 20230404 0000899243-23-010574.hdr.sgml : 20230404 20230404203917 ACCESSION NUMBER: 0000899243-23-010574 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230404 DATE AS OF CHANGE: 20230404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Camerlinck Robert CENTRAL INDEX KEY: 0001942114 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39289 FILM NUMBER: 23800843 MAIL ADDRESS: STREET 1: 9725 NW 117TH AVENUE, SUITE 200 CITY: MIAMI STATE: FL ZIP: 33178 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cano Health, Inc. CENTRAL INDEX KEY: 0001800682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9725 NW 117TH AVENUE, SUITE 200 CITY: MIAMI STATE: FL ZIP: 33178 BUSINESS PHONE: 2034227700 MAIL ADDRESS: STREET 1: 9725 NW 117TH AVENUE, SUITE 200 CITY: MIAMI STATE: FL ZIP: 33178 FORMER COMPANY: FORMER CONFORMED NAME: Jaws Acquisition Corp. DATE OF NAME CHANGE: 20200121 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-03-31 0 0001800682 Cano Health, Inc. CANO 0001942114 Camerlinck Robert CANO HEALTH, INC. 9725 NW 117TH AVENUE MIAMI FL 33178 0 1 0 0 Chief Operating Officer 0 Class A Common Stock 2023-03-31 4 A 0 70486 A 23913609 D Stock Option (Right to Buy) 0.91 2023-03-31 4 A 0 147548 0.00 A 2033-03-31 Class A Common Stock 147548 147548 D These shares represent restricted stock units ("RSUs") granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs vest as to 50% of the RSUs on December 31st, 2023 and the remaining 50% of the RSUs vest on December 31st, 2024. The RSUs were granted on March 31, 2023. The stock option is granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan and is scheduled to vest over four years, with 25% of the shares underlying the award vesting on March 31, 2024, and 25% of the shares underlying the award vesting at the end of each successive one-year period thereafter. The stock option was granted on March 31, 2023. /s/ David J. Armstrong, Attorney-in-Fact 2023-04-04